Company intelligence / Profile preview
Immune Network Ltd.
Vancouver, British Columbia, Canadaimmunenetwork.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Immune Network Ltd. developed a heat-inactivated, orally delivered Mycobacterium vaccae therapeutic vaccine that reached Phase 3 clinical trials for pulmonary tuberculosis. The company also pursued projects in Alzheimer’s disease, asthma, and AIDS but has since ceased active operations. Its oral TB immunotherapy was developed with Immunitor and entered Phase 2/3 trials as of the early 2010s. No recent clinical results are available.
- Therapeutic areas
- PulmonologyNeurologyInfectious Diseases
- Modalities
- Therapeutic vaccinesMonoclonal antibodiesImmunostimulants
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Immunitor company – partnered on oral TB immunotherapy developmentBridge Pharma Inc. – joint venture on asthma projectUniversity of British Columbia – collaboration with Dr. Brian Conway on AIDS research
Beyond the preview
Go deeper on Immune Network Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune Network Ltd..